Evidence map›Paper›PMID 42447158›Full record

ArticlePLoS neglected tropical diseases2026

A prediction model for mortality risk in melioidosis patients based on clinical and laboratory indicators: A single-center retrospective study.

Huimin Zhao, Pei Zhang, Shijia Li, Xuehan Duan, Hua Wu

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Huimin ZhaoDepartment of Clinical Laboratory, Hainan Women and Children's Medical Center (Hainan Medical University School of Pediatrics), Haikou, China.
Pei ZhangDepartment of Laboratory Medicine, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Xiuying, Haikou, Hainan, China.
Shijia LiDepartment of Laboratory Medicine, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Xiuying, Haikou, Hainan, China.
Xuehan DuanDepartment of Blood Transfusion, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Xiuying, Haikou, Hainan, China.
Hua WuDepartment of Clinical Laboratory, Hainan Women and Children's Medical Center (Hainan Medical University School of Pediatrics), Haikou, China.ORCID https://orcid.org/0000-0002-9140-0864

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melioidosis, caused by Burkholderia pseudomallei, carries a high mortality rate, particularly in acute severe cases. This study aimed to develop a practical prediction model for in-hospital mortality using routinely available clinical data. We retrospectively analyzed 283 melioidosis patients from Hainan General Hospital (2010-2024). Compared to survivors, non-survivors had significantly higher neutrophil percentage, C-reactive protein (CRP), and urea nitrogen levels, and lower platelet counts (PLT) (all P < 0.05) based on the last available measurements during hospitalization. Multivariate logistic regression identified these four variables as independent risk factors for mortality. A combined model integrating neutrophil percentage, PLT, CRP, and urea nitrogen demonstrated outstanding discriminative performance, with an area under the curve (AUC) of 0.957 (95% CI: 0.925-0.989), sensitivity of 94.9%, and specificity of 86.4%, significantly outperforming any single indicator. This high-accuracy model, based on inexpensive and universally available parameters, shows great potential for risk assessment during hospitalization of melioidosis patients in resource-limited endemic settings, facilitating timely intensive intervention.

Indexed as

MelioidosisAdultAgedBurkholderia pseudomalleiC-Reactive ProteinFemaleHospital MortalityHumansMaleMiddle AgedNeutrophilsPlatelet CountRetrospective StudiesRisk AssessmentRisk FactorsC-Reactive Protein

Identifiers

PMID42447158
PMCPMC13379109

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.